期刊文献+

血管生成素样蛋白2在糖尿病肾病小鼠肾脏中的表达研究 被引量:7

Expression of ANGPTL2 in The Kidney of Diabetic Nephropathy db/db Mice
下载PDF
导出
摘要 利用半定量RT-PCR和免疫组化的方法同时从mRNA水平和蛋白质水平对血管生成素样蛋白2在不同病理阶段的2型糖尿病肾病模型小鼠——db/db小鼠肾脏中的表达情况进行了较为系统的分析.结果发现:a.在糖尿病前的db/db小鼠(4周龄的db/db小鼠),血管生成素样蛋白2与作为正常对照的db/m小鼠相比,差异不是很大,随着肥胖的加剧,高血糖、蛋白尿的出现,血管生成素样蛋白2在db/db小鼠肾脏中的表达无论从mRNA水平还是从蛋白质水平均显著升高.b.从免疫组化的分析结果来看,血管生成素样蛋白2主要分布于小鼠肾脏的肾小球部分,主要是沿毛细血管袢呈线性分布,其位置与足细胞的位置重叠,足细胞是小鼠肾脏中血管生成素样蛋白2的主要分泌细胞.c.小鼠肾脏血管生成素样蛋白2的表达水平似乎还与鼠龄相关:虽然变化幅度不是很大,但在周龄较大的小鼠(如20周龄以上),其表达水平相对较高.上述工作不仅印证了先前对2型糖尿病肾病患者肾小球基因表达谱的分析结果,更加明确了血管生成素样蛋白2与糖尿病肾病的相关性,同时揭示了血管生成素样蛋白2在正常小鼠和糖尿病肾病小鼠肾脏中的表达、分布和变化规律,有利于进一步揭示血管生成素样蛋白2的功能及其在糖尿病肾病发生、发展过程中的可能作用,探讨糖尿病肾病的分子机制. Kidney samples were obtained from db/db mice and their db/m littermates at the age of 4, 8, 12, 16, 20 and 24 weeks. The expression of ANGPTL2 was assessed by RT-PCR and immunohistochemistry, and then correlated with biochemical and histological indices of kidney injury. No significant difference of ANGPTL2 expression was found in the kidney of db/db mice and the control db/m mice at the age of 4 weeks, a time when all biochemical and histological indices indicated that the db/db mice were in pre-diabetic condition. However, with the development of obesity, hyperglycemia and proteinuria, the expression of ANGPTL2 in the kidney of db/db mice increased, which indicated that the increased expression of ANGPTL2 associated with diabetic nephropathy. ANGPTL2 protein was found distributed mainly in the glomerulus. It is along the capillary loop, located just outside the basement membrane, and in the same location as podocytes, which suggested that podocytes are the main origin of ANGPTL2 in the kidney. Besides, increased expression of ANGPTL2 was found in older db/m mice though it has not reached to a significant level, which may suggest that ANGPTL2 might have some thing to do with the kidney injury caused by ageing.
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2008年第4期443-448,共6页 Progress In Biochemistry and Biophysics
基金 国家自然科学基金(30470801) 江苏省自然科学基金(BK2005086)资助项目~~
关键词 血管生成素样蛋白2 糖尿病肾病 DB/DB小鼠 angiopoietin-like protein 2 (ANGPTL2), diabetic nephropathy, db/db mice
  • 相关文献

参考文献21

  • 1陈建康,邹万忠,由江峰.内皮素与肾小球系膜细胞的关系[J].中华病理学杂志,1996,25(4):206-208. 被引量:26
  • 2郑敬民,刘志红,张鑫,黎磊石.db/db小鼠糖尿病肾病相关基因的分析和克隆[J].生物化学与生物物理进展,2003,30(3):406-411. 被引量:9
  • 3吴义超,刘志红,曾彩虹,苏健,陈朝红,黎磊石.糖尿病肾病患者肾小球基因表达谱及其与病情进展的关系[J].肾脏病与透析肾移植杂志,2004,13(6):503-511. 被引量:14
  • 4Like A A, Lavine R L, Poffenbarger P L, et al. Studies in the diabetic mutant mouse Ⅵ. Evolution of glomendar lesions and associated proteinuria. Am J Pathol, 1972, 66(2): 193-224
  • 5Coleman D L. Diabetes-obesity syndromes in mice. Diabetes, 1982, 31(suppl 1): 1-6
  • 6Kim I, Moon S O, Koh K N, et al. Molecular cloning, expression, and characterization of angiopoietin related protein. J Biol Chem, 1999, 274(37): 26523-26528
  • 7Loughna S, Sato T N. Angiopoictin and Tic signaling pathways in vascular development. Matrix Biol, 2001, 20(5-6): 319-325
  • 8Oike Y, Yasunaga K, Ito Y, et al. Angiopoictin-relatod growth factor (AGF) promotes epidermal proliferation, remodeling and regeneration. Proc Natl Acad Sci USA, 2003, 100(16): 9494-9499
  • 9Ito Y, Oike Y, Yasunaga K, et al. Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4. Cancer Res, 2003, 63(20): 6651-6657
  • 10Oike Y, Ito Y, Maekawa H, et al. Angiopoietin-related growth factor (AGF) promotes angiogenesis. Blood, 2004, 1039(10): 3760-3765

二级参考文献50

  • 1Matalon R, Rady P L, Platt K A, et al. Knock-out mouse for Canavan disease: a model for gene transfer to the central nervous system. J Gene Med, 2000, 2 (3): 165-175.
  • 2Sistermans E A, de Coo R F, van Beerendonk H M, et al.Mutation detection in the aspartoacylase gene in 17 patients with Canavan disease: four new mutations in the non-Jewish population.Eur J Hum Genet, 2000, 8 (7) : 557-560.
  • 3Baslow M H. Canavan's spongiform leukodystrophy: a clinical anatomy of a genetic metabolic CNS disease. J Mol Neurosci,2000, 15 (2): 61-69.
  • 4Tahmaz F E, Sam S, Hoganson G E, et al. A partial deletion of the aspartoacylase gene is the cause of Canavan disease in a family from Mexico. J Med Genet, 2001, 38 (3) : E9.
  • 5Janson C, McPhee S, Bilaniuk L, et al. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain. Hum Gene Ther, 2002, 13(11) : 1391-1412.
  • 6Baslow M H. Evidence supporting a role for N-acetyl-L-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review. Neurochem Int, 2002, 40(4): 295-300.
  • 7Coleman D L. Diabetes-obesity syndromes in mice. Diabetes,1982, 31 (suppl 1): 1-6.
  • 8Liu Z H, Li Y J, Chen Z H et al. Glucose transporter-1 in human glomerular mesangial cells modulated by transforming growth factor-beta and rhein. Acta pharmacol Sin, 2001, 22 (2): 169-175.
  • 9Wurmbach E, Yuen T, Ebersole, et al. Gonadotropin-releasing hormone receptor-coupled gene network organization. J Biol Chem,2001, 276 (50):47195-47201.
  • 10Tanaka T S, Jaradat S A, Lim M K, et al. Genome-wide expression profiling of mid-gestation placenta and embryo using a 15 000 mouse developmental cDNA microarray. Proc Natl Acad Sci USA, 2000, 97 (16): 9127-9132.

共引文献34

同被引文献55

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部